Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001842952-22-000030
Filing Date
2022-03-23
Accepted
2022-03-23 16:22:14
Documents
7
Effectiveness Date
2022-03-23

Document Format Files

Seq Description Document Type Size
1 S-8 cntxs-82022.htm S-8 46824
2 EX-FILING FEES cntx-formsx82022evergreenx.htm EX-FILING FEES 17957
3 EX-5.1 context-ex51opinionforform.htm EX-5.1 12636
4 EX-23.1 exhibit231consents-8.htm EX-23.1 2127
5 faegre.jpg GRAPHIC 39280
6 image_0a.jpg GRAPHIC 90
7 image_12a.jpg GRAPHIC 217
  Complete submission text file 0001842952-22-000030.txt   135461
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263789 | Film No.: 22763471
SIC: 2834 Pharmaceutical Preparations